Literature DB >> 11925113

Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer.

M R Andersen1, S Peacock, J Nelson, S Wilson, M McIntosh, C Drescher, N Urban.   

Abstract

OBJECTIVE: This study examined reports of perceived risk of ovarian cancer, worry, and screening use in a large sample of women. While screening for asymptomatic women is not generally recommended, in 1994 a consensus conference concluded that women with multiple affected relatives are at high risk for ovarian cancer and should be encouraged to participate in screening. The consensus report also suggested that women with a single affected first-degree relative are at elevated risk and while these women were not encouraged to get screening it was suggested that they may choose to pursue screening outside of a randomized trial [NIH Consensus Conference. JAMA 1995;273(6) 491-7].
METHODS: A total of 3257 women participated in this research by completing a mailed survey on ovarian cancer risk, worry, and use of screening. One hundred forty-two of these women were at high risk for this disease due to a strong family history. An additional 144 women were at elevated risk due to a single first-degree affected relative with ovarian cancer.
RESULTS: Family history did predict perceived risk, difficulties due to worry, and use of ovarian cancer screening. However, the group of women most likely to report high levels of perceived risk and to have received screening for ovarian cancer were women with a single affected relative rather than those at high risk, for whom screening is recommended.
CONCLUSIONS: These results suggest that many women need additional education about ovarian cancer risk. Most women overestimated their risk for this disease. Some average-risk women get screening although it is not recommended outside of randomized trials, and a significant percentage of women at high risk fail to get recommended screening.

Entities:  

Mesh:

Year:  2002        PMID: 11925113     DOI: 10.1006/gyno.2001.6556

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  17 in total

Review 1.  Reasons for and against participation in studies of medicinal therapies for women with breast cancer: a debate.

Authors:  Gero Luschin; Marion Habersack; Irmina-Anna Gerlich
Journal:  BMC Med Res Methodol       Date:  2012-03-11       Impact factor: 4.615

Review 2.  Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer.

Authors:  J R J De Leeuw; M J van Vliet; M G E M Ausems
Journal:  Fam Cancer       Date:  2008-03-14       Impact factor: 2.375

3.  Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer.

Authors:  M Robyn Andersen; Jason Thorpe; Diana S M Buist; J David Beatty; Kate Watabayashi; Nancy Hanson; Robert Resta; Jessica Chubak; Nicole Urban
Journal:  Behav Med       Date:  2014-11-03       Impact factor: 3.104

4.  Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors.

Authors:  Deborah J Bowen; Catherine M Alfano; Bonnie A McGregor; Alan Kuniyuki; Leslie Bernstein; Kathy Meeske; Kathy B Baumgartner; Josala Fetherolf; Bryce B Reeve; Ashley Wilder Smith; Patricia A Ganz; Anne McTiernan; Rachel Ballard Barbash
Journal:  Breast Cancer Res Treat       Date:  2007-01-27       Impact factor: 4.872

Review 5.  Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group.

Authors:  Marc T Kiviniemi; Jennifer L Hay; Aimee S James; Isaac M Lipkus; Helen I Meissner; Michael Stefanek; Jamie L Studts; John F P Bridges; David R Close; Deborah O Erwin; Resa M Jones; Karen Kaiser; Kathryn M Kash; Kimberly M Kelly; Simon J Craddock Lee; Jason Q Purnell; Laura A Siminoff; Susan T Vadaparampil; Catharine Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

6.  Patients' views on follow up of colorectal cancer: implications for risk communication and decision making.

Authors:  S Papagrigoriadis; B Heyman
Journal:  Postgrad Med J       Date:  2003-07       Impact factor: 2.401

7.  Cognitive and affective influences on perceived risk of ovarian cancer.

Authors:  Lucy A Peipins; Frances McCarty; Nikki A Hawkins; Juan L Rodriguez; Lawrence E Scholl; Steven Leadbetter
Journal:  Psychooncology       Date:  2014-06-11       Impact factor: 3.894

8.  Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Belinda Rahman; Kathy Tucker; Benjamin Cheah; Adrian Bickerstaffe; John Hopper; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

9.  Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening.

Authors:  Laura L Holman; Karen H Lu; Robert C Bast; Mary A Hernandez; Diane C Bodurka; Steven Skates; Charlotte C Sun
Journal:  Am J Obstet Gynecol       Date:  2013-11-16       Impact factor: 8.661

10.  Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening.

Authors:  L Fallowfield; A Fleissig; J Barrett; U Menon; I Jacobs; J Kilkerr; V Farewell
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.